|
|
FERTILIDADE:
ANTICONCEPÇÃO E INFERTILIDADE
Bahamondes,
L; Nascimento, JAA; Munuce, MJ; Fazano, F; Faúndes, A.
The in vitro effect of levonorgestrel on the acrosome reaction
of human spermatozoa from fertile men. Contraception,
68(1):55-9, 2003.

|
Hassan, DF; Petta, CA; Aldrighi, JM; Bahamondes, L; Perrotti, M.
Weigh variation in a cohort of women using copper IUD for contraception.
Contraception, 68(1):27-30, 2003.
 |
Faúndes, A; Brache, V; Alvarez, F. Emergency contraception
– Clinical and ethical aspects. International Journal of Gynecology
& Obstetrics,
82(2003):297-305.
 |
Alvarez, F;
Brache, V; Faúndes, A; Jorge, A; Sousa, MH. Local side
effects observed among long-term users of Norplant contraceptive
implants. Contraception, 68(2003):111-5.

|
Pedro, AO;
Pinto Neto, AM; Paiva, LHSC; Osis, MJ; Hardy, E. Idade de ocorrência
da menopausa natural em mulheres brasileiras: resultados de
um inquérito populacional domiciliar. Cad Saúde
Pública 19(1):17-25, 2003.

|
Hardy, E; Pádua,
KS de; Hebling, EM; Osis, MJD; Zaneveld, LJD. Women’s preferences
for vaginal antimicrobial contraceptives V: Attitudes of Brazilian
women to the insertion of vaginal products. Contraception
67(5), 391-95, 2003.
 |
Giacobbe, M; Zeferino, LC; Franzin, CM; Faundes, A.Uteroplacental
circulation during the first trimester of normal and abnormal
pregnancy. Reprod Biomed Online. 2002 Jan-Feb;4(1):62-7.

|
Pinto Neto, AM; Pedro, AO; Hardy, E; et al. Caracterização
das usuárias de terapia de reposição hormonal
do Município de Campinas, São Paulo. Cad
Saúde Pública, Fev 2002, 18(1):121-7.

|
Torres, JC; Derchain, SF; Faundes, A; Montijo, RC; Martinez, EZ;
Andrade, LA. Risk-of-malignancy index in preoperative evaluation
of clinically restricted ovarian cancer. Sao Paulo Med
J. 2002 May 2;120(3):72-6.

|
Guarisi, T; Pinto-Neto, AM; Herrmann, V; Faundes, A. Urodynamics
in climacteric women with urinary incontinence: correlation with
route of delivery. Int Urogynecol J Pelvic Floor Dysfunct.
2002;13(6):366-71. |
Croxatto, HB; Fuentealba, B; Brache, V; Salvatierra, AM; Alvarez,
F; Massai, R; Cochon, L; Faundes, A. Effects of the Yuzpe regimen,
given during the follicular phase, on ovarian function. Contraception.
2002 Feb;65(2):121-8.

|
Brache, V; Faundes, A; Alvarez, F; Cochon, L. Nonmenstrual adverse
events during use of implantable contraceptives for women: data
from clinical trials. Contraception. 2002 Jan;65(1):63-74.

|
Johansson, E; Brache, V; Alvarez, F; Faundes, A; Cochon, L; Ranta,
S; Lovern, M; Kumar, N. Pharmacokinetic study of different dosing
regimens of levonorgestrel for emergency contraception in healthy
women. Hum Reprod. 2002 Jun; 17 (6):1472-1476. |
Nascimento, R;
Bahamondes, L; Hidalgo, M; Perrotti, M; Espejo-Arce, X; Petta CA.
User’s perspectives on bleeding patterns after two years of
levonorgestrel-releasing intrauterine system use. Drugs
RD. 2002; 3(6)387-91. |
Monteiro, I; Bahamondes, L; Díaz, J; Perrotti, M; Petta,
C. Therapeutic use of levonorgestrel releasing intrauterine system
in women wih menorrhagia a pilot study(1). Contraception.
2002 May; 65(5):325-8

|
Hidalgo, M; Bahamondes, L; Perrotti, M; Díaz, J; Dantas-Monteiro,
C; Petta, C. Bleeding pattern and clinical performance of the
levonorgestrel-releasing intrauterine system (Mirena) up to two
years. Contraception. 2002 Feb; 65(2):129-32

|
Makuch, MY; Hardy, E. Mother-child relationship after in vitro fertilization.
Gynaecology Forum 2002; 7(4): 21-23. |
Perrotti, M; Bahamondes, L. Use of levonorgestrel-releasing intrauterine
system in women with menorragia: a review. Obs & Gynae
Today, 7(10):615-619, 2002. |
Pedro, AO; Pinto Neto, AM; Costa-Paiva, LHS; Osis, MJD; Hardy,
E. Climateric woman seeking medical care, Brazil. Rev
de Saude Pub 2002; 36(4):484-90.

|
Faúndes, A; Guarisi, T; Pinto-Neto, AM. The risk of urinary
incontinence of parous women who delivered only by cesarean section.
International Journal of Gynecology & Obstetrics,
72(2001) 41-46

|
Osis, MJD; Pádua, KS; Duarte, GA; Souza, TR; Faúndes,
A. The opinion of Brazilian women regarding vaginal labor and
cesarean section. International Journal of Gynecology
& Obstetrics, 75(2001) S59-S66.

|
Guarisi, T; Pinto Neto, AM; Osis, MJ; Pedro, AO; Paiva, LHC; Faúndes,
A. Incontinência. Urinária entre mulheres climatéricas
brasileiras: inquérito domiciliar. Rev Saúde
Pública; 35(5):428-35, 2001.

|
Bahamondes, L; Castillo, SD; Tabares, G; Arce, XE; Perroti, MA;
Petta, CA. Comparison of weight increase in users of depot medroxyprogesterone
acetate and copper IUD up to 5 years. Contraception,
64:223-225, 2001.

|
Brache, V; Mishell, DR; Lahteenmaki, P; Alvarez, F; Elomaa, K;
Jackanicz, T; Faúndes, A. Ovarian function during use of
vaginal rings delivering three different doses of NestoroneI.
Contraception, 63(5):257-261, 2001

|
Brache, V; Alvarez, F; Faúndes, A. Mechanism of action of
levonorgestrel contraceptive implants. Gynecol Endocrinol,
15(Suppl 2):14-20, 2001 |
Faúndes,
Ver Planejamento familiar no Brasil. Jornal da FEBRASGO,
3:4-5, 2001 |
Faúndes, A; Ávila, B; Araújo, MJ. Relatório
Final – Seminário “Implantes, DIU, Métodos
de Barreira: Situação atual no Brasil, a luz da saúde
e dos direitos sexuais e reprodutivos. Femina,
29(8):497-501, 2001. |
Galvão, L; Díaz, J; Díaz, M; Osis, MJD; Clark,
S; Ellertson, C. Anticoncepção de emergência:
conhecimento, atitude e práticas entre ginecologistas-obstetras
no Brasil. Perspectivas Internacionais em Planejamento
Familiar, número especial: 20-3 e 45, 2001.

|
Hardy, E; Duarte, GA; Osis, MJD; Arce, XE; Possan, M. Anticoncepção
de emergência no Brasil: facilitadores e barreiras. Cad
Saúde Públ, 17(4):1031-1035, 2001.

|
Hardy, E; Duarte, GA; Osis, MJD; Espejo-Arce, X; Possan, M. Aceitabilidade
da anticoncepção de emergência no Brasil. Femina,
29(10):717-720, 2001 |
Petta, CA; Hays, M; Brache, V; Massai, R; Hua, Y; Alvarez-Sánchez,
F; Croxatto, H; d’Arcangues, C; Cook, LA; Bahamondes, L.
Delayed first injection of the once-a-month injectable contraceptive
containing 25 mg of midroxiprogesterone acetate and 5 mg of E2-cypionate:
effects on ovarian function. Fertil and Steril,
75(4):744-748, 2001

|
Petta, CA;Hays, M; Brache, V; Massai, R; Hua, Y; Alvarez-Sánchez,
F; Croxatto, H; d’Arcangues, C; Cook, LA; Bahamondes, L.
Delayed first injection of the once-a-month injectable contraceptive
containing 25 mg medroxyprogesterone acetate and 5 mg estradiol-cypionate:
effects on cervical mucus. Contraception, 64:363-368,
2001

|
Perrotti, MA; Bahamondes, L; Petta, CA; Castro, SRN. Forearm bone
density in long-term users of oral combined contraceptives and
depot medroxyprogesterone acetate. Fertility & Sterility,
76(3):469-473, 2001

|
Welkovic, S; Costa, LOBF; Faundes, A; de Alencar Ximenes, R; Costa,
CF. Post-partum bleeding and infection after post-placental IUD
insertion. Contraception, 63(3):155-158, 2001.

|
Alvarez-Sanchez, F; Brache, V; Montes de Oca, V; Cochon, L; Faúndes,
A. Prevalence of enlarged ovarian follicles among users of levonorgestrel
subdermal contraceptive implants (Norplant). Am J Obstet
Gynecol, 182(3):535-539, 2000.

|
Bahamondes, L; Trevisan, M; Andrade, L; Marchi, NM; Castro, S;
Diaz, J; Faúndes, A. The effect upon the human vaginal
histology of the long-term use of the injectable contraceptive
Depo-Provera®. Contraception, 62(1):23-27,
2000.

|
Bahamondes, L. Metabolic effects of injectable contraceptives. Gynaecology
Forum, 5(1): 16-18, 2000. |
Bassol, S; Alvarado, A; Celis, C; Cravioto, MC; Peralta, O; Montano,
R; Novelli, J; Albornoz H, Kesseru E, Soares A, Petracco A, Isaia
B, Mendes J, Bahamondes L, Melo NR, Reyes-Marques R, Albrecht
G. Latin American experience with two low-dose oral contraceptives
containing 30 mg ethinylestradiol / 75 mg, gestodene and 20 mg
ethinylestradiol/150 mg desogestrel. Contraception,
62:131-135, 2000.

|
Biazotti, MCS; Martinez, EZM; Böttcher-Luiz, FA; Fazano, FA;
Sene, IS; Lucio, M; Bahamondes, L. Influências das características
do sêmen sobre os resultados de fertilização
“in vitro”. Jornal Brasileiro de Reprodução
Assistida, 4(1):11-18, 2000. |
Brache, V; Alvarez-Sanchez, F; Faúndes, A; Jackanicz, T;
Mishell, DR; Lahteenmaki, P. Progestin-only contraceptive rings.
Steroids, 65:687-691, 2000.

|
Brache, V; Massai, R; Mishell, DR; Alfred, M; Alvarez, F; Salvatierra,
AM; Cochon, L; Croxatto, H; Robbins, A; Faúndes, A. Ovarian
function during use of Nestorone® subdermal implants. Contraception,
61:199-204, 2000.

|
Diaz, J; Bahamondes, L; Monteiro, I; Petta, C; Hidalgo, MM; Arce,
X. Acceptability and performance of the levonorgestrel-releasing
intrauterine system IUD (Mirena) in Campinas. Contraception,
62:59-61, 2000.

|
Faúndes, A; Bossemeyer, R; Costa, RR; Codes, J. Planejamento
familiar dentro do contexto de saúde sexual e reprodutiva.
In: Andrade RP, Poli MEH, Petracco A, Morais KM, Camargos AF(eds.).
Contracepção – Promoção
da Saúde Sexual e Reprodutiva. Rio de Janeiro. Editora
Revinter, 2000.p.13-25. |
Faúndes, A; Faúndes, D. Anticoncepção
hormonal com implantes subdérmicos. In: Pinho Neto, JS (ed.)
Temas especiais de anticoncepção – FEBRASGO.
Rio de Janeiro. Editora Revinter, 2000. p. 175-190. |
Faúndes, D; Perdigão, A; Faúndes, A; Bahamondes,
L; Petta, CA. T-shaped IUDs accommodate in their position during
the first 3 months after insertion. Contraception,
62:165-168, 2000.

|
Petta, CA; Dantas, C; Hidalgo, MM & Bahamondes, L. Solicitações
de reversão de laqueadura em um serviço de esterilidade:
o problema continua. Reprod Clim, 15(4):214-217,
2000. |
Bahamondes, L; Díaz, J; Petta, C; Monteiro, I; Monteiro,
CD; Regina, CH. Comparison of the performances of the of Tcu 380A
and Tcu 380S IUDs up to five years. Advances in Contraception,
15:275-281, 1999.

|
Bahamondes, L; Perroti, M; Castro, SRN; Faúndes, D; Petta,
CA; Bedone, AJ. Forearm bone density in users of Depo-Provera
as contraceptive method. Fertility and Sterility,71(5):849-852,
1999.

|
Díaz, M; Simmons, R; Díaz, J; Gonzales, C; Makuch,
MY; Bossemeyer, D. Expanding Contraceptive Choice: Findings from
Brazil. Studies in Family Planning, 30(1): 1-16,
1999.

|
Faúndes, A; Petta, CA; Lucas D’Oliveira, AF; Carneiro,
LM; Souza, MJ; Costa, KS – A new scheme of diaphragm use:
evaluation of its effectiveness and acceptance. Gynecological
Endocrinology, 13(3):77, 1999. |
Faúndes, A; Alvarez, F; Brache, V; Cochón, L; Tejada,
AS; Moo-Young, A. Correlation of endocrine profiles with bleeding
patterns during use of Nestorone® contraceptive implants.
Human Reproduction, 14(12):3013-3017, 1999.

|
Faúndes, D; Neves, P; Petta, CA; Fazano, F; De Lucio, M;
Ramos, M; Faúndes, A. Efficiency of different ovulation induction
drugs in assisted reproduction. Gynecological Endocrinology,
13(3):39, 1999. |
Osis, MJD. Esterilização e gravidez na adolescência:
fatores inter-relacionados. In: Vieira, E. M. ; Fernandes, M.E.
; Bailey, P. ; Mckay, Ver (Org.). Gravidez na adolescência.
Associação Saúde da Família.
São Paulo. 1999. p.67-73. |
Osis, MJD; Faúndes, A; Souza, MH; Bailey, P. Conseqüências
do uso de métodos anticoncepcionais na vida das mulheres:
o caso da laqueadura tubária. Cadernos de Saúde
Pública 15(3):521-32, 1999

|
Bahamondes, LG; Maradiegue, E; Díaz, J; Trelles, J; Escanhoela
C.; Petta C.A.; Arce, XE. Endometrial Histology in Long-Term Users
of the Once-a-Month Injetable Contraceptive Cyclofem. Advances
in Contraception, 15:1-7, 1999

|
Galvão, L; Díaz, J; Díaz, M; Osis, MJ; Clark,
S; Ellertson, C. Emergency Contraception: Knowledge, Attitudes
and Practices Among Brazilian Obstetrician-Gynecologists. International
Family Planning Perspectives, 25(4):168-80, 1999.

|
Brache, V; Blumenthal, PD; Alvarez, F; Dunson, TR; Cochon, L;
Faúndes, A. Timing of onset of contraceptive effectiveness
in NorplantÒ Implante users II. Contraception,
59:245-51, 1999.

|
Hardy, E; Pádua, KS de; Osis, MJD; Jiménes, AL;
Zaneveld, LJD. Women’s preferences for vaginal antimicrobial
contraceptives IV – Attibutes of a formulation that would
protect from STD/AIDS. Contraception, 58:251-5,
1998

|
Hardy, E; Pádua, KS de; Jiménes, AL; Zaneveld, LJD.
Women’s preferences for vaginal antimicrobial contraceptives
III – Choice of a formulation, applicator, and packaging.
Contraception, 58:245-9, 1998

|
Hardy, E; Pádua, KS de; Jiménes, AL; Zaneveld, LJD.
Women’s preferences for vaginal antimicrobial contraceptives
II – Preferred characteristics according to women’s
age and socioeconomic status. Contraception,
58:239-44, 1998

|
Hardy, E; Pádua, KS de; Jiménes, AL; Zaneveld, LJD.
Women’s preferences for vaginal antimicrobial contraceptives
I – Methodology. Contraception, 58:233-8,
1998

|
Faúndes, A; Costa, RG; Pádua, KSP; Perdigão,
AM. Associação entre prevalência de laqueadura
tubária e características sócio-demográficas
de mulheres e seus companheiros no Estado de São Paulo,
Brasil. Cad Saúde Públ, Rio de
Janeiro, 14(Supl. 1):49-57, 1998.

|
Petta, CA; Faúndes, A; Dunson, TR; Ramos, M; DeLucio, M;
Faúndes, D; Bahamondes, L. Timing of onset of contraceptive
effectiveness in Depo-Provera users: Part I. Changes in cervical
mucus. Fertility and Sterility, 69(2):252-7,
1998.

|
Petta, CA; Faúndes, A; Dunson, TR; Ramos, M; DeLucio, M;
Faúndes, D; Bahamondes, L. Timing of onset of contraceptive
effectiveness in Depo-Provera users: Part II. Effects on ovarian
function. Fertility and Sterility, 70(5):817-820,
1998.

|
Alvarez, F; Brache, V; Tejada; AS; Cochon, L; Faúndez.
Sex hormone binding globulin and free levonorgestrel index in
the first week after insertion of NorplantÒ implants. Contraception,
58:211-4, 1998.

|
Faúndes, A; Alvarez, F; Brache, V; Cochón, L. Endometrial
thickness and oestradiol concentration in women with bleeding
complaints during use of NorplantÒ implants. Human
Reproduction, 13(1):188-91, 1998

|
Faúndes, A; Telles, E; Cristofoletti, M de L; Faúndes,
D; Castro, S; Hardy, E. The risk of inadvertent intrauterine device
insertion in women carriers of endocervical Chlamydia trachomatis.
Contraception, 58:105-9, 1998.

|
Faúndes, D; Bahamondes, L; Faúndes, A; Petta, CA.
T-Shaped IUD move vertically with endometrial growth and involution
during the menstrual cycle. Contraception, 57:413-5,
1998.

|
Gabiatti, JRE; Faúndes, A; Bahamondes, L; Faúndes,
D; Ramos, M; Fazano, F. A experiência de iniciar um
programa de fertilização in vitro em Hospital Universitário.
+, 13(4);221-7, 1998 |
Hardy, E; Santos, LC; Osis, MJ; Carvalho, G; Cecatti, JG; Faúndes,
A. Contraceptive use and pregnancy before and after introducing
lactational amenorrhea (LAM) in a postpartum program. Advances
in Contraception, 14:59-68, 1998.

|
Bahamondes, L; Lavin, P; Ojeda, G et al. Return of fertility after
discontinuation of the once-a-month injectable contraceptive cyclofem.
Contraception, 55:307-10, 1997.

|
|
|